(Q43199032)

15 November 2017

title

Jaw bone changes in rats after treatment with zoledronate and pamidronate (English)

1 reference

15 November 2017

Figen Cizmeci Senel

1

1 reference

15 November 2017

Mine Kadioglu Duman

2

1 reference

15 November 2017

Efnan Muci

3

1 reference

15 November 2017

Mustafa Cankaya

4

1 reference

15 November 2017

A Alper Pampu

5

1 reference

15 November 2017

Safak Ersoz

6

1 reference

15 November 2017

Omer Gunhan

7

1 reference

15 November 2017

publication date

8 January 2010

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

15 November 2017

published in

1 reference

15 November 2017

volume

109

1 reference

15 November 2017

issue

3

1 reference

15 November 2017

page(s)

385-391

1 reference

Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

The dental implications of bisphosphonates and bone disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: strategies for prevention and early recognition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

[Bisphosphonates and osteonecrosis of the jaw]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-associated osteonecrosis of the jaw

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

The science of bisphosphonate-related osteonecrosis of the jaws: the thin white line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Osteonecrosis of the jaw: more research needed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Intravenous bisphosphonates and osteonecrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Experimental and Clinical Pharmacology: Bisphosphonates - mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonates in bone diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Mandibular necrosis in beagle dogs treated with bisphosphonates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.10.011

10.1016/J.TRIPLEO.2009.10.011

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference